VEEV:NYSE
Veeva Systems Inc
$260.21
arrow_downward
-1.34%(-3.54) 1D
$260.21
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 18, 4:00:09 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for VEEV...
Open
$263.40
High
$263.74
Low
$259.09
Mkt. cap
42.13B
Avg. vol.
1.76M
Volume
6.00M
P/E ratio
42.55
52-wk high
$310.50
52-wk low
$148.05
EPS
$6.11
Beta
0.97
Shares outstanding
161.91M
No. of employees
8K
Open
$263.40
High
$263.74
Low
$259.09
Mkt. cap
42.13B
Avg. vol.
1.76M
Volume
6.00M
P/E ratio
42.55
52-wk high
$310.50
52-wk low
$148.05
EPS
$6.11
Beta
0.97
Shares outstanding
161.91M
No. of employees
8K
News stories
From web sources and news partners
The Globe and Mail
·
1 day ago
CFRA upgrades Veeva Systems (VEEV) to a Buy
CarePlus VietNam
·
2 weeks ago
VEEV Q2 2026 Earnings: EPS Beats Consensus by 3.69% on Rocky Guidance Landscape - CFO Commentary Report
CarePlus VietNam
·
1 month ago
Veeva (VEEV) Results Breakdown: Reported EPS Tops Expectations in the Latest Reading; Latest Reaction: Shares Move 1.85% Higher at the Close - Share Repurchase Impact
CarePlus VietNam
·
1 month ago
VEEV Q2 2026 Earnings: EPS Beats Estimates by 3%, Stock Slips 3.5% - Quarterly Profit Report
Profile
Veeva Systems Inc., headquartered in Pleasanton, California, provides cloud computing software, data, and consulting services for the life sciences industry. Its products are used to track all aspects of drug development and pharmaceutical manufacturing.
The company has 1,552 customers including Bayer, Boehringer Ingelheim, Eli Lilly and Company, Gilead Sciences, Merck & Co., Novartis, Alkermes plc, Alnylam Pharmaceuticals, bluebird bio, and Idorsia. Wikipedia
About Veeva Systems Inc
CEOPeter Gassner
Employees7.93K
Founded2007
HeadquartersPleasanton, California, United States
SectorHealth care
Websiteveeva.com